Free Trial
→ June 12: $100 Turns Into $100,000? (From Brownstone Research) (Ad)tc pixel Free SGRY Stock Alerts

Surgery Partners (SGRY) Competitors

Surgery Partners logo
$13.51 -0.26 (-1.89%)
Closing price 06/3/2026 04:00 PM Eastern
Extended Trading
$13.51 0.00 (0.00%)
As of 06/3/2026 06:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SGRY vs. THC, CELC, PACS, HIMS, and SHC

Should you buy Surgery Partners stock or one of its competitors? MarketBeat compares Surgery Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Surgery Partners include Tenet Healthcare (THC), Celcuity (CELC), PACS Group (PACS), Hims & Hers Health (HIMS), and Sotera Health (SHC). These companies are all part of the "medical" sector.

How does Surgery Partners compare to Tenet Healthcare?

Surgery Partners (NASDAQ:SGRY) and Tenet Healthcare (NYSE:THC) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Surgery Partners currently has a consensus target price of $22.18, suggesting a potential upside of 64.19%. Tenet Healthcare has a consensus target price of $244.16, suggesting a potential upside of 48.40%. Given Surgery Partners' higher possible upside, equities analysts plainly believe Surgery Partners is more favorable than Tenet Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
1 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.58
Tenet Healthcare
0 Sell rating(s)
4 Hold rating(s)
18 Buy rating(s)
0 Strong Buy rating(s)
2.82

Surgery Partners has a beta of 1.96, suggesting that its stock price is 96% more volatile than the broader market. Comparatively, Tenet Healthcare has a beta of 1.28, suggesting that its stock price is 28% more volatile than the broader market.

Tenet Healthcare has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Tenet Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.31B0.53-$77.90M-$0.60N/A
Tenet Healthcare$21.31B0.67$1.41B$19.238.56

Tenet Healthcare has a net margin of 7.94% compared to Surgery Partners' net margin of -2.28%. Tenet Healthcare's return on equity of 25.55% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners-2.28% 1.04% 0.41%
Tenet Healthcare 7.94%25.55%5.15%

In the previous week, Tenet Healthcare had 14 more articles in the media than Surgery Partners. MarketBeat recorded 16 mentions for Tenet Healthcare and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 1.50 beat Tenet Healthcare's score of 0.94 indicating that Surgery Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tenet Healthcare
10 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

95.4% of Tenet Healthcare shares are held by institutional investors. 2.0% of Surgery Partners shares are held by insiders. Comparatively, 1.0% of Tenet Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Tenet Healthcare beats Surgery Partners on 12 of the 16 factors compared between the two stocks.

How does Surgery Partners compare to Celcuity?

Surgery Partners (NASDAQ:SGRY) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

Surgery Partners has a beta of 1.96, suggesting that its stock price is 96% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.1, suggesting that its stock price is 90% less volatile than the broader market.

Surgery Partners has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Surgery Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.31B0.53-$77.90M-$0.60N/A
CelcuityN/AN/A-$177.04M-$3.90N/A

63.3% of Celcuity shares are held by institutional investors. 2.0% of Surgery Partners shares are held by company insiders. Comparatively, 13.3% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Surgery Partners presently has a consensus price target of $22.18, suggesting a potential upside of 64.19%. Celcuity has a consensus price target of $152.09, suggesting a potential upside of 70.98%. Given Celcuity's stronger consensus rating and higher probable upside, analysts clearly believe Celcuity is more favorable than Surgery Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
1 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.58
Celcuity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.83

Celcuity has a net margin of 0.00% compared to Surgery Partners' net margin of -2.28%. Surgery Partners' return on equity of 1.04% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners-2.28% 1.04% 0.41%
Celcuity N/A -244.61%-50.22%

In the previous week, Celcuity had 17 more articles in the media than Surgery Partners. MarketBeat recorded 19 mentions for Celcuity and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 1.50 beat Celcuity's score of -0.13 indicating that Surgery Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Celcuity
2 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
4 Very Negative mention(s)
Neutral

Summary

Surgery Partners beats Celcuity on 8 of the 15 factors compared between the two stocks.

How does Surgery Partners compare to PACS Group?

PACS Group (NYSE:PACS) and Surgery Partners (NASDAQ:SGRY) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

In the previous week, Surgery Partners had 1 more articles in the media than PACS Group. MarketBeat recorded 2 mentions for Surgery Partners and 1 mentions for PACS Group. Surgery Partners' average media sentiment score of 1.50 beat PACS Group's score of 0.00 indicating that Surgery Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Surgery Partners
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PACS Group has a net margin of 4.49% compared to Surgery Partners' net margin of -2.28%. PACS Group's return on equity of 26.47% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
Surgery Partners -2.28%1.04%0.41%

PACS Group has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.09$191.54M$1.5623.39
Surgery Partners$3.31B0.53-$77.90M-$0.60N/A

PACS Group presently has a consensus target price of $48.00, indicating a potential upside of 31.55%. Surgery Partners has a consensus target price of $22.18, indicating a potential upside of 64.19%. Given Surgery Partners' higher probable upside, analysts clearly believe Surgery Partners is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Surgery Partners
1 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.58

Summary

PACS Group beats Surgery Partners on 9 of the 13 factors compared between the two stocks.

How does Surgery Partners compare to Hims & Hers Health?

Surgery Partners (NASDAQ:SGRY) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk and dividends.

63.5% of Hims & Hers Health shares are owned by institutional investors. 2.0% of Surgery Partners shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Hims & Hers Health had 21 more articles in the media than Surgery Partners. MarketBeat recorded 23 mentions for Hims & Hers Health and 2 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 1.50 beat Hims & Hers Health's score of 0.84 indicating that Surgery Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
7 Very Positive mention(s)
8 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health has lower revenue, but higher earnings than Surgery Partners. Hims & Hers Health is trading at a lower price-to-earnings ratio than Surgery Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.31B0.53-$77.90M-$0.60N/A
Hims & Hers Health$2.35B2.71$128.37M-$0.09N/A

Surgery Partners presently has a consensus target price of $22.18, suggesting a potential upside of 64.19%. Hims & Hers Health has a consensus target price of $28.70, suggesting a potential upside of 4.40%. Given Surgery Partners' stronger consensus rating and higher possible upside, analysts plainly believe Surgery Partners is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
1 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.58
Hims & Hers Health
2 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.12

Hims & Hers Health has a net margin of -0.56% compared to Surgery Partners' net margin of -2.28%. Hims & Hers Health's return on equity of 6.10% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners-2.28% 1.04% 0.41%
Hims & Hers Health -0.56%6.10%1.52%

Surgery Partners has a beta of 1.96, indicating that its stock price is 96% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, indicating that its stock price is 137% more volatile than the broader market.

Summary

Hims & Hers Health beats Surgery Partners on 10 of the 16 factors compared between the two stocks.

How does Surgery Partners compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Surgery Partners (NASDAQ:SGRY) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Sotera Health presently has a consensus price target of $20.33, suggesting a potential upside of 33.16%. Surgery Partners has a consensus price target of $22.18, suggesting a potential upside of 64.19%. Given Surgery Partners' higher possible upside, analysts clearly believe Surgery Partners is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
Surgery Partners
1 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.58

In the previous week, Sotera Health and Sotera Health both had 2 articles in the media. Surgery Partners' average media sentiment score of 1.50 beat Sotera Health's score of 1.15 indicating that Surgery Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Surgery Partners
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

91.0% of Sotera Health shares are held by institutional investors. 15.4% of Sotera Health shares are held by company insiders. Comparatively, 2.0% of Surgery Partners shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Sotera Health has higher earnings, but lower revenue than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.16B3.74$77.94M$0.4137.24
Surgery Partners$3.31B0.53-$77.90M-$0.60N/A

Sotera Health has a net margin of 9.91% compared to Surgery Partners' net margin of -2.28%. Sotera Health's return on equity of 39.73% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health9.91% 39.73% 7.05%
Surgery Partners -2.28%1.04%0.41%

Sotera Health has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market. Comparatively, Surgery Partners has a beta of 1.96, indicating that its share price is 96% more volatile than the broader market.

Summary

Sotera Health beats Surgery Partners on 10 of the 15 factors compared between the two stocks.

Get Surgery Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SGRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SGRY vs. The Competition

Export
MetricSurgery PartnersMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.80B$8.45B$6.47B$12.54B
Dividend YieldN/A1.79%2.69%5.22%
P/E Ratio-22.5222.2322.1724.18
Price / Sales0.5319.03520.79112.26
Price / Cash8.0787.4841.3457.13
Price / Book0.565.079.846.72
Net Income-$77.90M$178.24M$3.57B$337.19M
7 Day Performance-1.03%-3.36%-2.46%-0.74%
1 Month PerformanceN/AN/AN/A-1.69%
1 Year Performance-41.41%2.00%26.49%33.10%

Surgery Partners Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SGRY
Surgery Partners
4.1516 of 5 stars		$13.51
-1.9%		$22.18
+64.2%		-42.0%$1.80B$3.31BN/A16,000
THC
Tenet Healthcare
4.0148 of 5 stars		$174.00
+0.1%		$244.16
+40.3%		-4.4%$14.97B$21.31B9.0599,000
CELC
Celcuity
2.9322 of 5 stars		$138.23
flat		$149.30
+8.0%		+645.0%$6.74BN/AN/A40
PACS
PACS Group
3.6933 of 5 stars		$37.78
+0.1%		$48.00
+27.1%		+258.4%$5.97B$5.29B24.2247,455
HIMS
Hims & Hers Health
2.9239 of 5 stars		$23.71
-0.2%		$28.90
+21.9%		-49.8%$5.41B$2.35BN/A2,442

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SGRY) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners
A gold storm is coming – are you ready?
The U.S. Treasury Secretary is betting big on gold - and the world's most successful investors are following s...
Traders Agency | Sponsoredtc pixel
The SpaceX S-1 changes everything
SpaceX just filed its IPO paperwork. And buried inside that filing was something that should change how every ...
Crypto 101 Media | Sponsoredtc pixel
How to claim a stake in SpaceX before the June 12 IPO
SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...
Brownstone Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
The chokepoint supplier behind SpaceX's $1.75 trillion empire
When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession...
Behind the Markets | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel